Conclusion
This risk-stratification model can facilitate the early prediction of disease progression in asymptomatic, severe presymptomatic, and non-severe presymptomatic patients based on 10 laboratory indicators and thereby help make appropriate clinical decisions and optimize the use of limited resources. This model and the 10 laboratory indicators can help improve the clinical management of COVID-19 patients who are at different stages of disease evolution.